Status:
UNKNOWN
Prostate Impendance Test Project
Lead Sponsor:
University of Pisa
Conditions:
Prostatic Neoplasms
PSA
Eligibility:
MALE
45+ years
Brief Summary
Impedance-based analysis could provide an adequate response to the need to identify a safe and reliable tool alternative to bioptic diagnosis. Patients who are candidates for prostate biopsy as suffer...
Eligibility Criteria
Inclusion
- age\> 45 years
- up of total PSA values beyond the normal range (\> 4 ng / ml)
- presence or absence of suspicious prostate nodule
Exclusion
- previous history of cancer
- BMI\>30
- patients with previous diagnosis of PIN HG at prostate core biopsy or in active surveillance
Key Trial Info
Start Date :
July 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03428087
Start Date
July 1 2017
End Date
June 30 2018
Last Update
February 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AOUP Ospedale cisanello
Pisa, Tuscany, Italy, 56124